|
Volumn 185, Issue 1, 2012, Pages 110-112
|
Immune effects of interferon gamma in persistent staphylococcal sepsis
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;
GAMMA INTERFERON;
HLA DR ANTIGEN;
INTERLEUKIN 10;
INTERLEUKIN 17;
INTERLEUKIN 2;
TRANSCRIPTION FACTOR AP 1;
TRANSCRIPTION FACTOR FOXP3;
TRANSCRIPTION FACTOR NFAT;
ADULT;
ANTIBIOTIC THERAPY;
ANTIGEN EXPRESSION;
ANTIGEN PRESENTATION;
BACTERIAL ARTHRITIS;
CASE REPORT;
CD4 LYMPHOCYTE COUNT;
CD4+ T LYMPHOCYTE;
CD8+ T LYMPHOCYTE;
CELL CYCLE;
CONTROLLED STUDY;
DOWN REGULATION;
DRUG EFFECT;
GENE EXPRESSION PROFILING;
GENE OVEREXPRESSION;
HUMAN;
HUMAN CELL;
INTENSIVE CARE UNIT;
LETTER;
LEUKOCYTE COUNT;
LUNG ABSCESS;
MALE;
METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NONHUMAN;
NONKETOTIC DIABETIC COMA;
PERIPHERAL BLOOD MONONUCLEAR CELL;
PRIORITY JOURNAL;
PROTEIN PHOSPHORYLATION;
PYURIA;
SIGNAL TRANSDUCTION;
STAPHYLOCOCCAL BACTEREMIA;
T LYMPHOCYTE ACTIVATION;
TREATMENT DURATION;
UPREGULATION;
|
EID: 84855265554
PISSN: 1073449X
EISSN: 15354970
Source Type: Journal
DOI: 10.1164/ajrccm.185.1.110 Document Type: Letter |
Times cited : (57)
|
References (7)
|